Episode 367: American Academy of Ophthalmology 2022 Meeting Retina Recap

Drs. Avni Finn and Shriji Patel join to discuss big takeaways from the 2022 AAO Annual Meeting, including discussion of biosimilars, dry AMD treatments, high-dose aflibercept, and private equity influence in the retina community.Relevant Financial Disclosures: Dr. Sridhar is a consultant for Alcon, Allergan, Apellis, DORC, Genentech, Ocuterra, and Regeneron. Dr. Finn is a consultant for Allergan and Genentech. Dr. Patel has no relevant disclosures.You can now claim CME credits via the AAO website. Visit https://www.aao.org/browse-multimedia?filter=Audi